Tips to avoid patent pitfalls as market for RNAi-derived therapeutics grows

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Tips to avoid patent pitfalls as market for RNAi-derived therapeutics grows

Sponsored by

Logo 22.07.22.png
Patented Patent Copyright Law Business technology concept.

Anne Marie Clark, senior patent searcher at CAS, looks at ways to protect and commercialise the promise of RNAi

The value and complexity of the patent landscape around RNA interference (RNAi) is increasing, creating special challenges for patent searches to protect IP and maximise its value.

RNAi is claimed in a variety of ways within patents. Standard terminology is not always used, and chemical modifications can be described a variety of ways. These inconsistencies mean that there is no single search strategy that can be used to efficiently and comprehensively retrieve this information from different data sources.

Read an in-depth discussion of relevant challenges and search techniques for RNAi in this resource from CAS

Click here to access CAS’s content hub on Managing IP

more from across site and SHARED ros bottom lb

More from across our site

The treatment of USPTO employees has been haphazard and shows a misunderstanding of how the IP office works and the challenges it faces
Jeff Kuester discusses why IP is the perfect party conversation and why excitement and stress are two of a kind
IP counsel Anna Bien and global marketing manager Lesia Tarasenko explain how the brewery secured an EUTM and the lessons they learned
Federal employees, including at the USPTO, have been ordered to justify their roles by outlining what they accomplished in the last week
Philips wins more than $2m in damages as Delhi High Court comes down hard on Indian DVD makers for wasting the court’s time
Public documents in a long-running feud between Brainchild and CPA Global provide more information about how CPA manages patent renewal costs
Tony Chen reveals the expansion goals for his new fully virtual practice, Chen IP, but why he won’t be cold-calling anyone
Daniel Tarr explains why returning to his former firm could help him establish his personal brand, and predicts what’s on the horizon for AI litigation
A call to reinstate the European Commission's controversial SEP proposal and a trademark row involving Stanley cups were also among the top talking points
Susman Godfrey and Polsinelli secured victory for power systems manufacturer Vicor at the US International Trade Commission
Gift this article